HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


TSI Corp.

Division of Sanofi

Latest From TSI Corp.

Biotechnology North of the Border

A venture-backed Canadian biotechnology industry is in its infancy, but faced with hostile capital markets, start-ups need clear exit plans. Consolidation's already started.
BioPharmaceutical Business Strategies

Keeping Track of Genzyme

Genzyme is that rare biotech company that is both profitable and diversified. To finance its entrepreneurial businesses without diluting its original shareholders, it has issued separate "tracking" stocks for its various wholly-owned divisions: Tissue Repair, Molecular Oncology, and its General division. The financing strategy brings tax advantages and a way to incentivize managers. But skeptics worry that it adds a complexity that will scare off investors.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • Robert Baldridge, Chmn. & Acting CEO
    Munro W Pitt, Senior VP & CFO
    Robert Horne, Sr. VP, Operations
    Paul Liebowitz, PhD, Director, Research & Development
  • Contact Info
  • TSI Corp.
    Phone: (508) 478-0877
    25 Birch St.
    Milford, MA 01757